
Let’s look at the key reasons that are pushing Ovid Therapeutics Inc (OVID) to new highs
Ovid Therapeutics Inc (NASDAQ: OVID) on Friday, plunged -10.75% from the previous trading day, before settling in for the closing price of $0.69. Within the
Ovid Therapeutics Inc (NASDAQ: OVID) on Friday, plunged -10.75% from the previous trading day, before settling in for the closing price of $0.69. Within the
Ovid Therapeutics Inc (NASDAQ: OVID) established initial surge of 4.65% at $0.7, as the Stock market unbolted on Wednesday, before settling in for the price
A new trading day began on Friday, with Ovid Therapeutics Inc (NASDAQ: OVID) stock price up 14.75% from the previous day of trading, before settling
Ovid Therapeutics Inc (NASDAQ: OVID) on Tuesday, plunged -7.28% from the previous trading day, before settling in for the closing price of $0.4. Within the
Ovid Therapeutics Inc (NASDAQ: OVID) on Monday, soared 10.52% from the previous trading day, before settling in for the closing price of $0.34. Within the
A new trading day began on Monday, with Ovid Therapeutics Inc (NASDAQ: OVID) stock price up 9.24% from the previous day of trading, before settling
Ovid Therapeutics Inc (NASDAQ: OVID) started the day on Thursday, with a price increase of 9.06% at $0.34, before settling in for the price of
On Monday, Ovid Therapeutics Inc (NASDAQ: OVID) was -6.57%% drop from the session before settling in for the closing price of $0.31. A 52-week range
A new trading day began on Monday, with Ovid Therapeutics Inc (NASDAQ: OVID) stock price up 3.71% from the previous day of trading, before settling
A new trading day began on Monday, with Ovid Therapeutics Inc (NASDAQ: OVID) stock price up 6.50% from the previous day of trading, before settling
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.